Safety and Pharmacokinetics of Orally Administered Gallium Maltolate in Various Refractory Malignancies

This study has been terminated.

Study NCT00050687 Information provided by Titan Pharmaceuticals

First Received: December 17, 2002 Last Updated: January 21, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	March 2005
Primary Completion Date:	March 2005 (Final data collection date for primary outcome measure)